Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation. [electronic resource]
Producer: 19970227Description: 79-85 p. digitalISSN:- 0268-3369
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Bone Marrow Transplantation -- immunology
- Combined Modality Therapy
- Female
- Follow-Up Studies
- Humans
- Injections, Subcutaneous
- Interleukin-2 -- administration & dosage
- Killer Cells, Natural -- drug effects
- Lymphocyte Subsets -- drug effects
- Lymphoma, Non-Hodgkin -- immunology
- Male
- Neoplasm, Residual
- Receptors, IgG -- analysis
- Recombinant Proteins -- administration & dosage
- Remission Induction
- T-Lymphocyte Subsets -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.